The AF Association provides support, information and guidance to anyone affected by atrial fibrillation (AF). AF Association works in partnership with patients and clinical experts to advance the education of both the medical profession and the general public on the risks, detection and treatment of AF.
Arrhythmia Alliance (A-A)
Arrhythmia Alliance is a coalition of charities, professional medical organisations and industry groups that works to promote the timely diagnosis and effective management of arrhythmias. By raising awareness and campaigning for the improved detection and care of heart rhythm disorders, Arrhythmia Alliance aims to extend and improve the lives of the millions around the world that these conditions effect.
AthenaDiaX sensor technology focuses on ECG recorders for patients at risk of heart rhythm disorders.
Cardiac diagnostic for patients at risk of / in need of atrial fibrillation, stroke; unclear syncope, dizziness, palpitations; cardiac infarction, sudden cardiac death; heart rhythm disorders; impaired cardiac output; heart failure; post ablation monitoring; medication effectiveness monitoring
Physicians in clinical or ambulatory environments with the following specialities: electrophysiology, neurology, pediatric cardiology, rehabilitation, cardiac surgery and sports medicine
The Bayer Group is a global enterprise with core competencies in the fields of health care, agriculture and high-tech materials. Bayer HealthCare, a subgroup of Bayer AG with annual sales of around EUR 20.0 billion (2014), is one of the world’s leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Medical Care and Pharmaceuticals divisions. Bayer HealthCare’s aim is to discover, develop, manufacture and market products that will improve human and animal health worldwide. Bayer HealthCare has a global workforce of 60,700 employees (Dec 31, 2014) and is represented in more than 100 countries. More information is available at www.healthcare.bayer.com.
BIOTRONIK ITALIA SpA
BIOTRONIK is a leading European manufacturer of medical technology with worldwide market presence and an unwavering patient focused philosophy. The company develops, manufactures and sells devices for cardiac rhythm management, ablation and vascular intervention. Its products aid the physician in saving lives and improving the quality of life for both patients and their families.
BIOTRONIK maintains R&D and production sites in Europe and North America, and markets its products in more than 100 countries on all continents. BIOTRONIK employs approximately 7.000 dedicated professionals worldwide, representing over 50 nationalities.
BOEHRINGER-INGELHEIM ITALIA SpA
The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, Boehringer Ingelheim operates globally with 146 affiliates and a total of more than 47,700 employees. The focus of the family-owned company, founded in 1885, is researching, developing, manufacturing and marketing new medications of high therapeutic value for human and veterinary medicine.
Social responsibility is an important element of the corporate culture at Boehringer Ingelheim. This includes worldwide involvement in social projects, such as the initiative “Making more Health” and caring for the employees. Respect, equal opportunities and reconciling career and family form the foundation of the mutual cooperation. In everything it does, the company focuses on environmental protection and sustainability.
In 2014, Boehringer Ingelheim achieved net sales of about 13.3 billion euros. R&D expenditure corresponds to 19.9 per cent of its net sales.
CARDIAC RHYTHM NEWS
Cardiac Rhythm News is a specialised, quarterly, newspaper dedicated to cardiac rhythm management specialists. It contains the latest news, opinion from thought leaders, summaries of cutting-edge research, expert analysis, conference coverage and updates on the latest products in the heart rhythm world.
Editorial Angela Gonzalez, email@example.com
Advertising – Noora Lobo, firstname.lastname@example.org
Journal of Atrial Fibrillation (JAFIB) is an open access journal with a special focus on physician and patient education. JAFIB publishes Featured Reviews, Original Research, Case Reports Journal Reviews and Editorials on atrial arrhythmias or any other interesting cases related to electrophysiology.
The Company Claber srl has its registered office and place of business in Vicenza, Strada Cattane n. 12. Here are the offices, which occupy an area of about 500 square meters and warehouse occupying a total area of about 600 square meters.Claber has business of reselling products exclusively for the areas of physical therapy, anesthesia, intensive care, urology, cardiac surgery, general and specialized surgery, cardiology and interventional radiology.Commercial activity is developed in the regions of Emilia Romagna, Lombardia, Piemonte, Valle d\\\’Aosta, Trentino Alto Adige, Veneto and Friuli Venezia Giulia.In 2010 Claber srl has obtained the certification of Quality – ISO 9001 (2008), ISO 13485 (2012) and EN 46001 the certifying (IMQ).CLABER srl is able to ensure a consistent and effective technical assistance which is carried out by our product specialists and commercial office (customer service). On the basis of the requests / inputs received, they will provide timely information about improvements in the production, information for the description and encoding of the material, technical updates to the medical staff.The company is also able to provide after-sales support with educational materials, paper, electronic and / or audiovisual.We are also able to deliver material particularly urgent within 24 hours of receipt of the order and / or replace components of the toolkits, delivered on loan for use, possibly worn out, taking advantage of our employees / specialists / employees of the area, which will be also available whenever required to provide every possible support to the good use of our toolkits and systems and will provide assistance if necessary during surgery.
Daiichi Sankyo Europe GmbH
Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical products to address diversified, unmet medical needs of patients
in both mature and emerging markets.
With over 100 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 17,000 employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people.
In addition to its strong portfolio of medicines for hypertension, dyslipidemia, bacterial infections, and thrombotic disorders, the Group’s research and development is focused on bringing forth novel therapies in cardiovascular-metabolic diseases, pain management, and oncology, including biologics.
ECAS (European Cardiac Arrhythmia Society)
ECAS is a non-profit organization (association), registered in Marseille, France in August 2004 (Article 1) governed by the law of July 1, 1901 and located “Place 2, Delibes, 13008 Marseille, France”.
Objective: the “Society”, has as its purpose to promote excellence in the care of patients with cardiac rhythm disorders (Article 2) and promote education of the general public.
Various categories of membership: MDs, Scientists, fellows, technicians, nurses (See Membership Program)
website : www.ecas-heartrhythm.org
Tel : +33 4 89 14 45 33
Mobile: +336 26 07 55 74
FIAB SpA is an Italian Company manufacturing and marketing worldwide devices and accessories for temporary cardiac pacing and electrophysiology. Leader manufacturer of esophageal cardiac stimulation devices, FIAB has developed and patented the system Esotest for the esophageal temperature monitoring during AF ablation procedures.
H. + H. Maslanka Chirurgische Instrumente GmbH
H. + H. Maslanka Chirurgische Instrumente GmbH was founded in 1974. With over 40 years of experience in the field of medical technology, Maslanka is synonymous with high-quality products and developments across the whole endoscopy sector.
Our clients include medical technology companies, pharmaceutical firms, hospitals and physicians. Maslanka offers customer-specific designs and production facilities based in Germany.
Johnson & Johnson Medical SpA – Div. Biosense Webster
Biosense Webster, a division of Johnson & Johnson Medical SpA, is an international leader in the development, production and marketing of innovative solutions for the diagnosis and treatment of cardiac arrhythmias. Its product portfolio is among the largest in the sector and is supported by a series of services ranging from clinical support to education, from trainings for new users to the organization of scientific seminars
Medico is an Italian manufacturing Company devoted to Cardiac Rhythm Management.
Thanks to an established tradition of commitment, passion and technological evolution, Medico spa continues to be at the forefront of progress in cardiac pacing.
Pacing devices and Cardiac resynchronization systems have been designed and developed to ensure top medical technology, allowing the physicians to suit the pacing therapy to the needs of every single patient.
Our exclusive TVI and i-ECG signals can be considered as an eye inside the heart: cardiac mechanic and electric function are both constantly controlled to provide hemodynamic monitoring in the long term. Come to visit us! We’ll show you more details.
Medtronic Italia S.p.A
Medtronic is the global leader in medical technology, alleviating pain, restoring health and extending life for millions of people around the world. With deep roots in the treatment of heart disease, Medtronic now provides a wide range of products and therapies – every three seconds, another life is improved by a Medtronic product or therapy.The company was founded in 1949 in Minneapolis, Minnesota, USA, by Earl E. Bakken and Palmer J. Hermundslie. Medtronic has been present in Europe since 1967.
Pfizer is dedicated to better health and greater access to healthcare for people. Its purpose is helping people live longer, healthier, happier lives and the route to that purpose is through discovering and developing breakthrough medicines; providing information on prevention, wellness, and treatment; consistent high-quality manufacturing of medicines; and global leadership in corporate responsibility. Pfizer products are available in more than 150 countries. The company presence in Italy dates back to 1955. www.pfizer.it
PLACE 2015, Platform of Laboratories for Advances in Cardiac Experirence is the evolution of ACE – Advances in Cardiac Electrophysiology.An Event that turns into a Platform, a dynamic “place” that interacts inboth time and space within our scientific community.Laboratory, namely a multidisciplinary whole of diverse knowledge, experimentally exchanging views with its own target, looking at the several Advances we live and witness daily, among the different scenarios of the Cardiac Experience.
Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and Genzyme.
Sorin Group (www.sorin.com), is a global medical device company and a leader in the treatment of cardiovascular diseases. The Company develops, manufactures and markets medical technologies for cardiac surgery and for the treatment of cardiac rhythm disorders. With 3.900 employees worldwide, the Company focuses on two major therapeutic areas: Cardiac Surgery (cardiopulmonary products for open heart surgery and heart valve repair or replacement products) and Cardiac Rhythm Management (pacemakers, defibrillators, cardiac resynchronization devices). Every year, over one million patients are treated with Sorin Group devices in more than 100 countries.
St. Jude Medical Italia Spa
St. Jude Medical was founded in 1976 in St. Paul, Minnesota, USA, as a pioneering manufacturer of bi-leaflet implantable mechanical heart valves. Our innovative heart valve design soon became the “gold standard” for mechanical heart valves.
Since its first major acquisition of Pacesetter™ in 1994, St. Jude Medical has continued to grow into a global leader in cardiac and neurological device technology, broadening our product portfolio through internal development and strategic acquisitions.
We are driven by our vision and mission to transform the treatment of expensive epidemic diseases, including atrial fibrillation, heart failure, stroke, coronary artery disease, congenital heart defects, Parkinson’s disease and chronic pain. St. Jude Medical is uniquely positioned to achieve our goal by providing innovative solutions that reduce the economic burden of costly diseases on health care systems worldwide and provide improved outcomes for patients.
Syncope Trust And Reflex anoxic Seizures (STARS)
STARS is the leading patient advocacy organisation providing guidance and information on syncope, a common cause of unexplained blackouts or faints. STARS aims to ensure that anyone with unexplained loss of consciousness receives timely diagnosis, effective treatment, support and direction to appropriate medical professionals.
The 13th International Dead Sea Symposium (IDSS) on Innovations in Technology, Treatment & Prevention of Cardiac Arrhythmias
The 2016 IDSS symposium is scheduled for March 6-9, 2016, and will focus broadly on emerging technology and therapies and will comprise all phases of the innovation process, e.g. ongoing or recently completed studies on devices, ablation, and mapping. This approach will facilitate comprehensive exposure to medical device and biotechnology innovations. The International Program Committee in close collaboration with leading scientific societies is preparing a multidisciplinary scientific program for professionals in all disciplines of arrhythmia: electrophysiologists, clinical cardiologists, innovative scientists, biomedical engineers, entrepreneurs and the industry. The program will highlight numerous hot topics such as multidisciplinary approaches in treatment of AF, HF and prevention of sudden cardiac death. Mini-courses on ECG, CRT, AF and VT ablation and cardiac anatomy will also be included in the program. The 13th IDSS will be held in the elegant and picturesque venue of the David InterContinental Hotel & Convention Center, Tel Aviv.
Wisepress Medical Bookshop
Wisepress are Europe’s principal conference bookseller. We exhibit the leading books, sample journals and digital content relevant to this meeting. Books may be purchased at the booth, and we offer a postal service. Visit our online bookshop for special offers and follow us on Twitter for the latest news @WisepressBooks.
XVII International Symposium on Progress in Clinical Pacing
XVII International Symposium on Progress in Clinical Pacing 2016 will be held in Rome, Italy on November 29 – December 2, 2016, under the auspices of the most important International Scientific Societies.The Scientific Program will deal with the most interesting topics, technological innovations, new diagnostic and therapeutic technique, health economy. The expected faculty will include more than 500 scientists coming from various Continents.Furthermore there will be organized once more, the Course for Allied Professionals which is usually attended by more than 300 nurses and technicians .